Internal Medicine · Muncie, IN
NPI
1225355613
Since 2010
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
1910 W Royale Dr
Muncie, IN, 47304
Phone (765) 289-1011
Groups this clinician bills Medicare through
Medicare paid, 2024
$571K
20,615 services
Medicare patients, 2024
1,177
Average age 76
Drug cost, 2024
$1.9M
13,634 prescriptions
Company payments, 2025
$2,361
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Margaret R Zelasko was code 36415 (venipuncture blood collection), 1,111 times for 368 patients. In total Margaret R Zelasko billed 20,615 services in 97 codes, and Medicare paid $571K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 1,111 | 368 | $8.63 | $9,593 |
| G0008 Administration of influenza virus vaccine | Office | 941 | 941 | $30.10 | $28K |
| 99214 Office E&M - Established | Office | 940 | 361 | $76.36 | $72K |
| 90653 Vaccine Product | Office | 914 | 914 | $81.82 | $75K |
| 80061 Clinical Chemistry | Office | 661 | 356 | $13.04 | $8,620 |
| 91320 Vaccine Product | Office | 650 | 649 | $152.71 | $99K |
| 90480 Vaccine Administration | Office | 650 | 649 | $40.13 | $26K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 648 | 297 | $10.37 | $6,722 |
| 85025 Blood Count | Office | 502 | 347 | $7.59 | $3,813 |
| 84443 Clinical Chemistry | Office | 496 | 338 | $16.39 | $8,131 |
| 83036 Blood Count | Office | 477 | 311 | $9.46 | $4,512 |
| 84439 Clinical Chemistry | Office | 476 | 336 | $8.80 | $4,190 |
| 80053 Clinical Chemistry | Office | 461 | 345 | $10.33 | $4,761 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 418 | 50 | $44.30 | $19K |
| 80048 Clinical Chemistry | Office | 411 | 257 | $8.25 | $3,391 |
By year: 2022 $522K for 25,425 services; 2023 $533K for 21,086 services; 2024 $571K for 20,615 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,111 | 368 | $8.63 | $9,593 |
| 80061 Clinical Chemistry | 661 | 356 | $13.04 | $8,620 |
| 85025 Blood Count | 502 | 347 | $7.59 | $3,813 |
| 84443 Clinical Chemistry | 496 | 338 | $16.39 | $8,131 |
| 83036 Blood Count | 477 | 311 | $9.46 | $4,512 |
| 84439 Clinical Chemistry | 476 | 336 | $8.80 | $4,190 |
| 80053 Clinical Chemistry | 461 | 345 | $10.33 | $4,761 |
| 80048 Clinical Chemistry | 411 | 257 | $8.25 | $3,391 |
| 82607 Clinical Chemistry | 363 | 335 | $14.74 | $5,350 |
| 82570 Clinical Chemistry | 326 | 318 | $5.06 | $1,651 |
Medicare prescription drug claims, 2024
In 2024, the drug Margaret R Zelasko prescribed most often to Medicare patients was Atorvastatin Calcium, with 710 prescriptions and refills. In total Margaret R Zelasko wrote 13,634 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 710 | 2,042 | 194 | $8,671 |
| Amlodipine Besylate Generic | 620 | 1,710 | 168 | $4,243 |
| Rosuvastatin Calcium Generic | 578 | 1,634 | 145 | $8,731 |
| Levothyroxine Sodium Generic | 525 | 1,460 | 125 | $4,404 |
| Metoprolol Succinate Generic | 412 | 1,125 | 112 | $5,517 |
| Hydrochlorothiazide Generic | 369 | 1,035 | 105 | $1,639 |
| Valsartan Generic | 300 | 781 | 90 | $14K |
| Omeprazole Generic | 295 | 863 | 91 | $3,946 |
| Metformin Hcl Er Metformin Hcl | 288 | 834 | 89 | $3,278 |
| Boostrix Tdap Diphth,pertuss(Acell),tet Vac | 281 | 281 | 281 | $20K |
| Escitalopram Oxalate Generic | 251 | 690 | 66 | $2,989 |
| Gabapentin Generic | 248 | 675 | 78 | $6,247 |
| Lisinopril Generic | 222 | 609 | 61 | $1,329 |
| Pantoprazole Sodium Generic | 203 | 571 | 58 | $3,216 |
| Sertraline Hcl Generic | 195 | 497 | 48 | $2,014 |
Brand drugs: 2,378 claims; generic drugs: 11,169 claims; opioid claims: 319.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Margaret R Zelasko $2,361 ($2,361 in general payments such as food, travel and fees) from 29 companies. The largest payer was Abbvie Inc. with $450.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 41 | $450 |
| AstraZeneca Pharmaceuticals LP AZN | 17 | $383 |
| Pfizer Inc. PFE | 17 | $234 |
| Novo Nordisk Inc NVO | 13 | $207 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $95.42 |
| Exact Sciences Corporation EXAS | 4 | $71.75 |
| Lilly USA, LLC LLY | 3 | $67.69 |
| Biosense Webster, Inc. JNJ | 1 | $63.74 |
| Medtronic, Inc. MDT | 3 | $55.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.